Molecular Imaging
Sophisticated cancer detection innovation
Cyclopharm's Molecular Imaging division was established mid 2006. This division aims to:
operate PET central pharmacies in Australia to produce sterile, injectable, unit PET doses or molecular biomarkers.
provide diagnositic imaging services such as Macquarie Medical Imaging.
provide PET equipment; cyclotrons, synthesisers, dispensers and associated products necessary to operate PET central pharmacies in Asia Pacific excluding North America. This equipment is sourced under an exclusive licence from Cyclopharma Laboratoires SA, a leading European molecular imaging company.
For further information on the Technegas Plus Generator please use this link which will direct you to the home page to choose the region applicable to you.
